semaglutide and perimenopause Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Compounded Semaglutide for Perimenopause |

Peptide Combination and Research Synergy The combination of BPC-157 and TB-500 is often investigated in experimental settings due to their different but complementary activity profiles

Introduction - Conscious Skincare Solutions for Tired Eyes The reflection staring back at us often tells a story of our day, our week, our life

Our idea of a page turner

WHO backs GLP-1 meds to treat obesity, but many Islanders can't access them Only 20% of Canadians have access to these medications through insurance, says nurse practitioner As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity , a Halifax-based expert says the change likely wont bring immediate improvements for Prince Edward Islanders

Some patients notice improved energy levels and subtle skin clarity within 2 to 3 weeks of beginning treatment